Biolife Sciences (Biolife Sciences) Accounts Payable & Accrued Expense : $0.43 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Accounts Payable & Accrued Expense?

Biolife Sciences's quarterly accounts payable & accrued expense declined from Nov. 2007 ($0.72 Mil) to Feb. 2008 ($0.65 Mil) and declined from Feb. 2008 ($0.65 Mil) to May. 2008 ($0.43 Mil).

Biolife Sciences's annual accounts payable & accrued expense increased from Nov. 2005 ($0.20 Mil) to Nov. 2006 ($0.35 Mil) and increased from Nov. 2006 ($0.35 Mil) to Nov. 2007 ($0.72 Mil).

Biolife Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biolife Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Accounts Payable & Accrued Expense Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Accounts Payable & Accrued Expense

0.20

0.35

0.72

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										0.50	0.47	0.72	0.65	0.43

Biolife Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020